The following data is part of a premarket notification filed by Boston Biomedica, Inc. with the FDA for Accurun 135 Toxoplasma Igg Positive Control.
| Device ID | K974261 |
| 510k Number | K974261 |
| Device Name: | ACCURUN 135 TOXOPLASMA IGG POSITIVE CONTROL |
| Classification | Antisera, If, Toxoplasma Gondii |
| Applicant | BOSTON BIOMEDICA, INC. 375 WEST ST. West Bridgewater, MA 02379 |
| Contact | Patricia E Garrett |
| Correspondent | Patricia E Garrett BOSTON BIOMEDICA, INC. 375 WEST ST. West Bridgewater, MA 02379 |
| Product Code | LJK |
| CFR Regulation Number | 866.3780 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 1997-11-13 |
| Decision Date | 1997-12-11 |
| Summary: | summary |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 00816784020390 | K974261 | 000 |